Article info
Diagnostics
Original research
Transcriptome-based variant calling and aberrant mRNA discovery enhance diagnostic efficiency for neuromuscular diseases
- Correspondence to Murim Choi, Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea; murimchoi{at}snu.ac.kr; Jong-Hee Chae, Department of Pediatrics, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea; chaeped1{at}snu.ac.kr
Citation
Transcriptome-based variant calling and aberrant mRNA discovery enhance diagnostic efficiency for neuromuscular diseases
Publication history
- Received November 1, 2021
- Accepted March 8, 2022
- First published April 6, 2022.
Online issue publication
October 21, 2022
Article Versions
- Previous version (6 April 2022).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.